Completed
A Phase 1 Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies
NCT00807677
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Advanced Polycythemia, +47 more
- Locations
-
- University of Michigan Ann Arbor, Michigan, United States